Healthcare Services (HCSG) EBITDA Margin (2009 - 2026)

Healthcare Services has disclosed EBITDA Margin across 18 years of filings, most recently posting 5.55% for Q1 2026.

• In Q1 2026, EBITDA Margin rose 159.0% year-over-year to 5.55%; the TTM figure through Mar 2026 stood at 3.72% (up 132.0% YoY), while the FY2025 annual figure was 3.32%, up 104.0% from the prior year.
• EBITDA Margin fell to 5.55% in Q1 2026, from 6.76% in the prior quarter.
• Over the last five years, EBITDA Margin for HCSG reached as high as 9.4% in Q3 2025 and fell as low as 6.98% in Q2 2025.
• The 5-year median for EBITDA Margin is 3.09% (2023), against an average of 2.56%.
• The widest YoY moves for EBITDA Margin: up 564 bps in 2025, down 645 bps in 2025.
• A 5-year view of EBITDA Margin shows it stood at 4.2% in 2022, then jumped by 49 bps to 6.24% in 2023, then plunged by 63 bps to 2.31% in 2024, then soared by 192 bps to 6.76% in 2025, then retreated by 18 bps to 5.55% in 2026.
• According to Business Quant data, EBITDA Margin over the past three periods registered 5.55%, 6.76%, and 9.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.